Støyten M, Knutsen T, Thune I, Stikbakke E, Wilsgaard T, Eggen AE, Richardsen E, Giovannucci E, Schirmer H, Haugnes HS (2026)
Cardiac Function and Prostate Cancer Risk and Prognosis: The PROCA-Life Study
Clin Genitourin Cancer, 102508 (in press)
DOI 10.1016/j.clgc.2026.102508, PubMed 41688223

Brandal SHB, Mo T, Fangberget A, Nilsen LB, Geier OM, Bjørndal H, Holmen MM, Engebråten O, Garred Ø, Hole KH, Seierstad T (2026)
MRI for Predicting Response and 10-Year Outcome of Neoadjuvant Chemotherapy with or Without Additional Bevacizumab Treatment in HER2-Negative Breast Cancer
Cancers (Basel), 18 (3)
DOI 10.3390/cancers18030393, PubMed 41681863

Svalheim KG, Andresen NK, Bjerre C, Gilje B, Jakobsen EH, Falk RS, Naume B, Kaasa S, Kyte JA (2026)
Patient-reported outcomes from the randomized ALICE trial evaluating the addition of atezolizumab to anthracycline-based chemotherapy in metastatic triple-negative breast cancer
Breast, 86, 104704 (in press)
DOI 10.1016/j.breast.2026.104704, PubMed 41581361